Amplimune® (100-dose)
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Amplimune® (20-dose)
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Amplimune® (5-dose)
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Immunocidin® (canine)
Immunocidin, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the intratumoral treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.
Immunocidin® Equine
Immunocidin Equine, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the intratumoral treatment of sarcoid tumors in horses.
Change Country
If your country is not listed, please call us at 613-391-3837 or e‑mail sales@novavive.ca.
Australia
Canada
New Zealand
U.S.A.
United Arab Emirates